Technological advances are affecting all areas of life and nowhere is their impact as critical as in the fields of medicine and healthcare. An aging global population has made healthcare costs a concern for governments worldwide, which explains their push to harness the power of technology in medical services delivery. Patients themselves are becoming increasingly aware of the benefits telemedicine can offer, using new devices and software apps to send their doctors information about vital signs such as blood pressure and heart rate. The ability of telemedicine to help physicians who are taking care of critically ill patients, such as those in a comatose state, is the next step forward. Frank Magliochetti, Managing Partner at Massachusetts-based financial restructuring specialist Parcae Capital Corporation, believes in the value of robotic telemedicine, and points to the findings of a study in which the Mayo Clinic Hospital in Arizona established its effectiveness in assessing levels of consciousness (LOC) in comatose patients.
The first of its kind, this study aimed to prove that bedside and remote assessments are equivalent when dealing with ICU patients who have decreased LOC. The research team recruited 16 doctors, randomly assigning two to each patient and using the Glasgow Coma Scale (GCS) and the Full Outline of UnResponsiveness (FOUR) score to compare the reliability of the two assessment methods. The bedside and remote physician assessors then compared these scores. The study took 15 months and involved 100 comatose patients whose mean age was 70.8 years. One clinician in the pair assessed the patient assigned to them at the bedside, while the other conducted the assessment via real-time audio and a visual robotic telemedicine system. The data analysis showed that remote and beside assessment produced GCS and FOUR scores that differed only slightly. In addition, the medical practitioners conducting the remote assessment expressed strong overall satisfaction with this method and its ease of use.
According to Frank Magliochetti, the findings of the Mayo Clinic study add to a growing body of data that indicates new medical technology can transform patient care. It enables the delivery of critical decisions in a matter of seconds, allowing doctors to communicate in real time and save lives. Telemedicine is already helping critical care specialists in ICUs and providing medical expertise to underserved areas. It is also catching the attention of employers, some of whom have made telemedicine part of their strategies to keep health costs down through preventive care for their employees.
Frank Magliochetti’s success is the result of his expert knowledge in two areas: medicine and finance. Having obtained a B.S. in Pharmacy from Northeastern University, Magliochetti enrolled in the school’s Masters of Toxicology program. He later received an MBA from The Sawyer School of Business at Suffolk University, with a specialty in corporate finance. Shortly after graduating Northeastern, Frank Magliochetti founded a pharmacy chain, which he eventually sold. He has held senior positions at Baxter International, Kontron Instruments, Haemonetics Corporation, and Sandoz. In his current position at Parcae Capital, Frank focuses on financial restructuring and interim management services for companies in the healthcare, media, and alternative energy industries.
Frank Magliochetti – Parcae Capital – North Andover: http://frankmagliochetti.com